Australia secures onshore manufacturing agreements for 2 COVID-19 vaccines

Image of vials of vaccines

A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successful, following a $1.7 billion supply and production agreement between the Australian Government and pharmaceutical companies.

Under the agreement, the University of Oxford/AstraZeneca and the University of Queensland/CSL will provide more than 84.8 million vaccine doses for the Australian population, almost entirely manufactured in Melbourne, with early access to 3.8 million doses of the University of Oxford vaccine in January and February 2021.

Read the full media release.

/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.